HCC Monitor
September 2016
Volume: 2
Issue: 3
June 2016
Volume: 2
Issue: 3
April 2016
Volume: 2
Issue: 1
October 2015
Volume: 1
Issue: 3
July 2015
Volume: 1
Issue: 2
April 2015
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
